Pfizer Inc
(NEOE:ZPFE)
C$
9.93
(0%)
Market Cap: 56.60 Bil
Enterprise Value: 127.76 Bil
PE Ratio: 18.54
PB Ratio: 1.54
GF Score: 57/100 
Pfizer Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:10PM GMT
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Okay. Great. Thank you. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and I have great pleasure to start with Dr. Dave Denton from Pfizer.
David M. Denton
Pfizer Inc. - CFO & Executive VP
I love it.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris Stevo from Pfizer. So Dave is the CFO of the Pfizer and he recently started in May of this year.
David M. Denton
Pfizer Inc. - CFO & Executive VP
Yes, exactly. Exactly.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris, I think it is almost a year for you.
Christopher J. Stevo;
Pfizer Inc. - Senior VP & Chief IR Officer
Correct. Just over a year actually.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers